Additionally, one other retrospective study of 76 patients in all breast cancer subtypes (23 TNBC cases) found improved rates of pCR with neoadjuvant chemotherapy (74.3% vs. 40%) were associated with high CD68 and PD-L1 expression using monoplex IHC43. The gene discussed is CD68; the disease is breast cancer.